Sh. Hussaini et al., ROLES OF GALL-BLADDER EMPTYING AND INTESTINAL TRANSIT IN THE PATHOGENESIS OF OCTREOTIDE INDUCED GALL-BLADDER STONES, Gut, 38(5), 1996, pp. 775-783
Background-Octreotide treatment of acromegalic patients increases the
% deoxycholic acid conjugates and the cholesterol saturation of gall b
ladder bile, and induces gall stone formation. Aims-To study the roles
of gall bladder emptying and intestinal transit in these phenomena. M
ethods and patients-Gall bladder emptying and mouth to caecum transit
was measured in (a) control subjects and acromegalic patients given sa
line or 50 mu g of octreotide, and (b) acromegalic patients taking lon
g term octreotide. In the second group, large bowel transit was also m
easured. Results-A single dose of octreotide inhibited meal stimulated
gall bladder emptying, the ejection fraction falling from mean (SEM)
66.0 (2.3)% to 7.0 (5.3)% in controls (p<0.001); from 72.5 (2.1) to 16
.6 (5.1)% in untreated acromegalic patients (p<0.001), and to 30.4 (9.
5)% in acromegalic patients taking long term octreotide (p<0.001 v unt
reated acromegalic group). Octreotide prolonged mouth to caecum transi
t time, from 112 (15) min to 237 (13) min in controls (p<0.001), from
170 (13) min to 282 (11) min in untreated acromegalic patients (p<0.00
1), and to 247 (10) min in acromegalic patients taking long term octre
otide (p<0.001 v untreated acromegalic patients). The mean large bowel
transit in octreotide untreated compared with treated acromegalic pat
ients remained unchanged (40 (6) h v 47 (6) h). Conclusions-Prolongati
on of intestinal transit and impaired gall bladder emptying may contri
bute to lithogenic changes in bile composition and gall stone formatio
n in patients receiving long term octreotide.